Related Experiment Video
Updated: Jun 5, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Progress and problems in understanding and managing primary Epstein-Barr virus infections
Oludare A Odumade1, Kristin A Hogquist, Henry H Balfour
1Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, MMC 437, 420 Delaware St. SE, Minneapolis, MN 55455-0392, USA.
Abstract:
Epstein-Barr virus (EBV) is a gammaherpesvirus that infects a large fraction of the human population. Primary infection is often asymptomatic but results in lifelong infection, which is kept in check by the host immune system. In some cases, primary infection can result in infectious mononucleosis. Furthermore, when host-virus balance is not achieved, the virus can drive potentially lethal lymphoproliferation and lymphomagenesis. In this review, we describe the biology of EBV and the host immune response. We review the diagnosis of EBV infection and discuss the characteristics and pathogenesis of infectious mononucleosis. These topics are approached in the context of developing therapeutic and preventative strategies.
Insights
Epstein-Barr virus (EBV) causes lifelong infections, sometimes leading to infectious mononucleosis or cancers. Understanding EBV biology and immune responses is key to developing new therapies and prevention strategies.
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Epstein-Barr virus (EBV), a common gammaherpesvirus, establishes lifelong infections in a majority of the human population.
- While often asymptomatic, EBV primary infection can manifest as infectious mononucleosis and, if immune control fails, lead to lymphoproliferation and lymphomagenesis.
- The host immune system plays a critical role in maintaining latent EBV infection.
Purpose of the Study:
- To comprehensively review the biology of Epstein-Barr virus.
- To elucidate the host immune response to EBV infection.
- To discuss diagnostic methods, pathogenesis, and therapeutic/preventative strategies for EBV-related conditions.
Main Methods:
- Review of existing literature on EBV biology, immunology, and clinical manifestations.
- Synthesis of information regarding diagnosis and pathogenesis of infectious mononucleosis.
- Analysis of current and potential future therapeutic and preventative approaches.
Main Results:
- EBV infects a large proportion of humans, establishing lifelong latency controlled by the immune system.
- Uncontrolled EBV infection can result in infectious mononucleosis, lymphoproliferation, and cancer.
- Effective immune surveillance is crucial for managing EBV.
Conclusions:
- A thorough understanding of EBV biology and host immune responses is fundamental for managing EBV infections.
- Developing novel therapeutic and preventative strategies requires integrating knowledge of EBV pathogenesis and diagnosis.
- Future research should focus on enhancing immune control and developing targeted interventions against EBV-driven diseases.
Related Concept Videos
Encephalitis ll: Pathophysiology
Genital Herpes
Stages of Infection
Smallpox
Encephalitis l: Introduction
Viral Hepatitis I: Introduction

